News | January 07, 2026
Dr. Lal PathLabs launches tech-driven personalized wellness center 'Sovaaka'
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
Heart failure affects an estimated 64.3 million people worldwide
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
Elanco expects Befrena to launch in the US in the first half of 2026
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Under the 2023 collaboration agreement, Assembly Bio will receive $35 million for Gilead’s exercise of the HSV program option
Subscribe To Our Newsletter & Stay Updated
